Bioorganic and Medicinal Chemistry Letters p. 1572 - 1575 (2019)
Update date:2022-08-29
Topics:
Olawode, Emmanuel O.
Tandlich, Roman
Prinsloo, Earl
Isaacs, Michelle
Hoppe, Heinrich
Seldon, Ronnett
Warner, Digby F.
Steenkamp, Vanessa
Kaye, Perry T.
A series of novel, substituted 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones have been prepared and shown to exhibit promising concentration-dependent activity against human SH-SY5Y cells, Plasmodium falciparum, Mycobacterium tuberculosis and P. aeruginosa. Substituent effects on observed bioactivity have been explored; the para-fluorophenyl derivative 3d exhibited activity across the range of the bioassays employed, indicating the potential of the 2-chloro-3-[(4-arylthiazol-2-yl)amino]-1,4-naphthoquinone scaffold in the development of novel, broad spectrum therapeutics.
View Morepuyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Chengdu Sino-Strong Pharmaceutical Co.,Ltd.
website:http://www.sino-strong.com.cn
Contact:+86-28-82666753
Address:459 West haike road,Cross-straits technological industry park, Wenjiang district,Chengdu, P.R.China
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Doi:10.1039/b718544h
(2008)Doi:10.1007/s11164-012-0962-6
(2014)Doi:10.1021/jm020871e
(2002)Doi:10.1016/0040-4020(96)00903-9
(1996)Doi:10.1002/hlca.19720550712
(1972)Doi:10.1021/ic010661c
(2002)